Literature DB >> 17387385

Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.

Judit Kiss1, József Tímár, Beáta Somlai, Katalin Gilde, Zsuzsanna Fejôs, István Gaudi, Andrea Ladányi.   

Abstract

Vascularization and host response to malignant tumors may have common molecular regulators, therefore, we analyzed the relationship between microvessel density (MVD) and tumor infiltrating cells in cutaneous malignant melanoma. Density of lymphocyte subpopulations, macrophages, dendritic cells and CD34(+) microvessels was determined by immunohistochemistry in primary tumor samples from fifty-two patients with melanoma thicker than 1 mm. Intratumoral MVD did not show significant association with infiltration for any of these cell types. In the case of peritumoral reactive cell densities analyzed in the whole patient population, a positive correlation of MVD was found with CD3(+) T cell density. This association was stronger in melanomas >4.0 mm and in visceral metastatic tumors. In these subgroups similar phenomenon was observed for CD8(+) cells. We found significant correlation of MVD with CD68(+) macrophage density only in the highest thickness category, and weak associations with B-cell and dendritic cell infiltration in visceral metastatic cases. MVD did not vary significantly in tumors categorized according to thickness, localization, ulceration or histological type. However, both intratumoral MVD and macrophage infiltration were significantly higher in male patients compared to females. The correlation of immune cell density with tumor vascularization and gender differences in vascularity and macrophage infiltration of melanoma deserve further attention.

Entities:  

Mesh:

Year:  2007        PMID: 17387385     DOI: 10.1007/bf02893437

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  64 in total

Review 1.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

Review 2.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

3.  Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues.

Authors:  Shao-Hua Peng; Hong Deng; Jian-Feng Yang; Ping-Ping Xie; Cheng Li; Hao Li; De-Yun Feng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 4.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 5.  Phenotype and functions of intratumoral macrophages.

Authors:  W H McBride
Journal:  Biochim Biophys Acta       Date:  1986-08-05

6.  Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.

Authors:  Marc Colombel; Stéphanie Filleur; Pierick Fournier; Carole Merle; Julien Guglielmi; Aurélie Courtin; Armelle Degeorges; Claire Marie Serre; Raymonde Bouvier; Philippe Clézardin; Florence Cabon
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

Review 7.  2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

Authors:  V S Pribluda; E R Gubish; T M Lavallee; A Treston; G M Swartz; S J Green
Journal:  Cancer Metastasis Rev       Date:  2000       Impact factor: 9.264

8.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

9.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.

Authors:  E B Bröcker; G Zwadlo; B Holzmann; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

View more
  9 in total

Review 1.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

2.  Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma.

Authors:  Sook Jung Yun; Shujing Liu; Meghan Buckley; Tao Wang; Suna Jin; Giorgos Karakousis; Madalyn G Peters; David E Elder; Phyllis A Gimotty; Xiaowei Xu
Journal:  Hum Pathol       Date:  2019-04-06       Impact factor: 3.466

Review 3.  Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

Authors:  Iris Helfrich; Dirk Schadendorf
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

4.  Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.

Authors:  Uma N M Rao; Sandra J Lee; Weixiu Luo; Martin C Mihm; John M Kirkwood
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

5.  Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells.

Authors:  Hitoe Torisu-Itakura; Hans F Schoellhammer; Myung-Shin Sim; Reiko F Irie; Susanne Hausmann; Tobias Raum; Patrick A Baeuerle; Donald L Morton
Journal:  J Immunother       Date:  2011-10       Impact factor: 4.456

6.  Sex-dependent liver colonization of human melanoma in SCID mice--role of host defense mechanisms.

Authors:  Judit Dobos; Anita Mohos; József Tóvári; Erzsébet Rásó; Tamás Lőrincz; Gergely Zádori; József Tímár; Andrea Ladányi
Journal:  Clin Exp Metastasis       Date:  2012-12-01       Impact factor: 5.150

7.  T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Authors:  Natalie J Neubert; Martina Schmittnaegel; Natacha Bordry; Sina Nassiri; Noémie Wald; Christophe Martignier; Laure Tillé; Krisztian Homicsko; William Damsky; Hélène Maby-El Hajjami; Irina Klaman; Esther Danenberg; Kalliopi Ioannidou; Lana Kandalaft; George Coukos; Sabine Hoves; Carola H Ries; Silvia A Fuertes Marraco; Periklis G Foukas; Michele De Palma; Daniel E Speiser
Journal:  Sci Transl Med       Date:  2018-04-11       Impact factor: 17.956

Review 8.  Hypoxia Signaling in Cancer: From Basics to Clinical Practice.

Authors:  Anna Sebestyén; László Kopper; Titanilla Dankó; József Tímár
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201

Review 9.  Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis.

Authors:  Konstantinos Perivoliotis; Panagiotis Ntellas; Katerina Dadouli; Prodromos Koutoukoglou; Maria Ioannou; Konstantinos Tepetes
Journal:  J Skin Cancer       Date:  2017-12-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.